Literature DB >> 9284526

Control of papillomavirus DNA replication and transcription.

C Desaintes1, C Demeret.   

Abstract

Hallmarks of HPV infection include a restricted tropism for human epithelial cells and a viral life cycle tightly linked to the differentiation program of the host keratinocyte. This particular viral cycle has hampered the study of the HPV vegetative life cycle for decades, due to the lack of suitable in-vitro culture conditions. The tissue and differentiation dependence seems to be dictated by viral transcription rather than viral DNA replication. Indeed, viral transcription is restricted to epithelial cells of human origin, more specifically to keratinocytes. In contrast, HPV genomes can replicate in various undifferentiated cell lines regardless of their natural permissiveness to infection, as long as the viral replication proteins E1 and E2 are expressed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9284526     DOI: 10.1006/scbi.1996.0043

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  19 in total

1.  Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain.

Authors:  S Bellanger; C Demeret; S Goyat; F Thierry
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

Authors:  Sophie Bellanger; Chye Ling Tan; Yue Zhen Xue; Sébastien Teissier; Françoise Thierry
Journal:  Am J Cancer Res       Date:  2011-01-24       Impact factor: 6.166

3.  A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.

Authors:  K W Vance; M S Campo; I M Morgan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.

Authors:  Long Fu Xi; Mark Schiffman; Yang Ke; James P Hughes; Denise A Galloway; Zhonghu He; Ayaka Hulbert; Rachel L Winer; Laura A Koutsky; Nancy B Kiviat
Journal:  Int J Cancer       Date:  2017-01-24       Impact factor: 7.396

5.  Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Cosette M Wheeler; Denise A Galloway; Constance Mao; Jesse Ho; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

6.  Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alpha(1)-globin and human cytokeratin 7.

Authors:  Darja Kanduc
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Expression of the HPV11 E2 gene in transgenic mice does not result in alterations of the phenotypic pattern.

Authors:  Kerstin Leykauf; Kirsten Kabsch; Nikolaus Gassler; Lutz Gissmann; Angel Alonso; Johannes Schenkel
Journal:  Transgenic Res       Date:  2007-08-16       Impact factor: 2.788

8.  KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8.

Authors:  W Zhang; S Hong; K P Maniar; S Cheng; C Jie; A W Rademaker; A M Krensky; C Clayberger
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

9.  Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Authors:  Woei Ling Peh; Kate Middleton; Neil Christensen; Philip Nicholls; Kiyofumi Egawa; Karl Sotlar; Janet Brandsma; Alan Percival; Jon Lewis; Wen Jun Liu; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 10.  Evolutionary and biophysical relationships among the papillomavirus E2 proteins.

Authors:  Dukagjin M Blakaj; Narcis Fernandez-Fuentes; Zigui Chen; Rashmi Hegde; Andras Fiser; Robert D Burk; Michael Brenowitz
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.